Department of Medical and Surgical Sciences, Institute of Respiratory Diseases, Azienda Ospedaliero Universitaria Foggia, Foggia, Italy.
Respiration. 2017;93(4):296-300. doi: 10.1159/000457804. Epub 2017 Feb 9.
Necrotizing granulomatous diseases of the lungs are usually dependent on a narrow range of differential diagnoses. Tuberculosis (TB) is responsible for the largest number of cases, while necrotizing sarcoidosis is generally considered a rare and easily distinguishable disease substantially based on histological features. However, this entity has become a viable diagnosis in the absence of mycobacteria isolation or when a remarkable clinical improvement cannot be achieved with the combination of anti-TB drugs at full dosage. The classic manifestations of TB and sarcoidosis have an overlapping range for which it is sometimes difficult to make a clinical diagnosis. Furthermore, the role of mycobacteria as a trigger antigen capable of evoking the clinical expression of sarcoidosis is a hypothesis supported by evidence from some cases. We report a case of bilateral tuberculous pleurisy in a 45-year-old male native of a North-African region with an atypical severe multisystem disease characterized by a fever resistant to anti-TB therapy and respondent to corticosteroid treatment. The choice to continue both steroid and anti-TB therapy proved to be correct for the late evidence of TB mycobacterial growth only on pleural specimens. The case described is suggestive of a coexistent systemic sarcoid manifestation and low-antigen TB, which is an underrecognized entity in the medical literature.
肺部坏死性肉芽肿性疾病通常依赖于一系列狭窄的鉴别诊断。结核病(TB)是导致这种疾病的最主要原因,而坏死性结节病通常被认为是一种罕见的疾病,主要基于组织学特征即可轻易区分。然而,在没有分离出分枝杆菌或在全剂量抗结核药物联合治疗无法实现显著临床改善的情况下,这种疾病成为一种可行的诊断。TB 和结节病的典型表现有一定的重叠范围,因此有时难以做出临床诊断。此外,分枝杆菌作为一种能够引发结节病临床表现的触发抗原的作用,是一些病例所支持的假设。我们报告了一例来自北非地区的 45 岁男性双侧结核性胸膜炎病例,他患有非典型严重多系统疾病,表现为发热,对抗结核治疗有耐药性,对皮质类固醇治疗有反应。选择继续使用类固醇和抗结核治疗是正确的,因为只有胸腔标本中发现了结核分枝杆菌生长的晚期证据。所描述的病例提示存在共存的系统性结节病表现和低抗原性 TB,这在医学文献中是一种认识不足的实体。